M.O. Sydnes et al. / Tetrahedron 65 (2009) 3863–3870
3869
exchange experiments (D-MS and D-MS/MS) the column was
equilibrated with 260 L D2O containing 0.025% D-trifluoroacetic
acid at a flow rate of 10 L/min and then developed using a linear
gradient from 0 to 100% acetonitrile containing 0.025% D-tri-
fluoroacetic acid at a flow rate of 5 L/min. The column effluent was
monitored at 210 nm and then introduced into the electrospray
nebulizer without splitting. For H-MS and H-MS/MS the column
was equilibrated with isocratic 40% acetonitrile/water containing
(E-isomer), 14.2 (E-isomer), 14.1 (Z-isomer), five signals from the
aromatic rings associated with the Z-isomer and the signal from the
carbonyl carbon associated with both isomers could not be dis-
m
m
cerned; 19F NMR (CDCl3, 376 MHz)
d
ꢁ36.3 (E-isomer), ꢁ40.1
m
(Z-isomer), ꢁ49.2 (Z-isomer), ꢁ46.5 (E-isomer); MS (EIþ) m/z 398
ꢃ
(Mþ , 68%), 353 (22), 213 (86), 185 (46), 157 (98), 140 (100), 112 (97),
ꢃ
101 (77), 51 (37); HRMS (EIþ) found: Mþ , 398.0872. C18H14F4N2O4
ꢃ
requires Mþ , 398.0890; tR in HPLC 17.75 min (E-isomer) and
0.025% trifluoroacetic acid at a flow rate of 5
mL/min. For the proton
11.48 min (Z-isomer).
exchange experiments (D-MS and D-MS/MS) the column was
equilibrated with isocratic 40% acetonitrile/D2O containing 0.025%
4.6. Hydrazine 14
D-trifluoroacetic acid at a flow rate of 5 mL/min. Selected MS and
MS/MS spectra were also measured utilizing syringe injection ion
trap HCT Plus mass spectrometer (Bruker Daltonics, Bremen, Ger-
many) equipped with an orthogonal ESI source. Data were acquired
and processed using Compass version 1.2 (esquireControlÔ and
DataAnalysisÔ version 3.2) (Bruker Daltonics, Bremen, Germany),
respectively. All MS experiments were preformed in the positive
ion mode.
Sodium dithionite (13.6 mg, 0.0782 mmol) was added to a solu-
tion of azobenzenes 13a and 13b (3.0 mg, 0.00753 mmol) stirred at
reflux in a mixture of MeOH/H2O/CH2Cl2 (1.0 mL/1.0 mL/0.15 mL).
The resulting reaction mixture was heated at reflux for 1.3 h before
being cooled to room temperature and poured into ice-water
(10 mL). The aqueous phase was extracted with Et2O (2ꢀ20 mL) and
the combined organic fractions were dried over Na2SO4. Filtration
and concentration gave a dark yellow oil, which was subjected to
preparative TLC (hexane/EtOAc 4:1) to afford fractions A and B.
Concentration of fraction A (Rf 0.46) gave 1.1 mg (37%, recovery)
of compound 13a as a yellow solid, which was identical, in all re-
spects, with the starting material.
4.3. Ethyl 3-azido-4,6-difluorobenzoate (12)
1H NMR (CF3CD2OD, 400 MHz)
d
7.57 (dd, J¼7.0 and 9.0 Hz, 1H),
6.84 (t, J¼10.6 Hz, 1H), 4.28 (q, J¼7.2 Hz, 2H), 1.27 (t, J¼7.2 Hz, 3H).
For the remaining spectroscopic data see Ref. 8.
Concentration of fraction B (Rf 0.38) gave 1.9 mg of a 3.8:1
mixture of hydrazine 14 and starting material 13a as a yellow solid.
This implements that 1.5 mg (50%, at 50% conversion) of the desired
4.4. Ethyl 3-amino-4,6-difluorobenzoate (15)
hydrazine 14 was formed. 1H NMR (CDCl3, 400 MHz)
d 7.57 (dd,
1H NMR (CF3CD2OD, 400 MHz)
d
7.40 (dd, J¼7.2 and 9.6 Hz, 1H),
J¼6.8 and 9.6 Hz, 2H), 6.91 (dd, J¼10.0 and 10.8 Hz, 2H), 4.34 (q,
6.77 (t, J¼10.6 Hz, 1H), 4.25 (q, J¼7.2 Hz, 2H), 1.26 (t, J¼7.2 Hz, 3H).
J¼7.2 Hz, 4H), 1.35 (t, J¼7.2 Hz, 6H); 1H NMR (CF3CD2OD, 400 MHz)
For the remaining spectroscopic data see Ref. 8.
d
7.49 (t, J¼8.2 Hz, 2H), 6.81 (t, J¼10.6 Hz, 2H), 4.20 (q, J¼7.2 Hz, 4H),
1.20 (t, J¼7.2 Hz, 6H); 19F NMR (CDCl3, 376 MHz)
d
ꢁ53.5, ꢁ61.3; MS
ꢃ
4.5. Azobenzenes 13a and 13b
(EIþ) m/z 400 (Mþ , 20%), 200 (28), 155 (100), 127 (82), 101 (32), 100
ꢃ
ꢃ
(22); HRMS (EIþ) found: Mþ , 400.1003. C18H16F4N2O4 requires Mþ
,
To a stirred solution of amine 16 (62.3 mg, 0.309 mmol) was
added a solution of KOH (47.4 mg, 0.845 mmol in 1.5 mL EtOH/
water 1:1) followed by slow addition of potassium ferricyanide
(408.3 mg, 1.24 mmol). The resulting reaction mixture was heated
at reflux for 7 h before being cooled to room temperature, filtered,
and diluted with CH2Cl2 (10 mL). The aqueous phase was acidified
with 1 N HCl and extracted with CH2Cl2 (3ꢀ10 mL). The combined
organic fractions were dried over Na2SO4. Filtration and concen-
tration under reduced pressure gave a dark orange oil, which was
diluted with EtOH (20 mL) and H2SO4 (10 drops) was added. The
resulting reaction mixture was heated at reflux for 3 h before being
cooled to room temperature and diluted with EtOAc (40 mL). The
organic phase was washed with brine/water (1ꢀ10 mL of a 1:1
mixture) and brine (1ꢀ10 mL) before being dried over Na2SO4.
Filtration and concentration gave a dark yellow oil, which was
subjected to flash chromatography (silica, hexane/EtOAc/Et3N
90:9.95:0.05/85:14.95:0.05). Concentration of the relevant fractions
(Rf 0.4 in hexane/EtOAc 85:15) gave 4.1 mg (7%) of the desired
product as a yellow solid and as a 3:1 mixture of E (13a) and Z (13b)
400.1046; tR in HPLC 9.62 min.
4.7. Isolation of azoxybenzene 19
The photolysis mixture was purified by HPLC (Cosmosil 5C18-AR
(10ꢀ250 nm), CH3CN/H2O 4:1, 2.0 mL/min, 295 nm). Concentration
of the relevant fraction under reduced pressure gave a light-yellow
oil. 1H NMR (CF3CD2OD, 400 MHz)
d
8.87 (t, J¼8.0 Hz, 1H), 8.51 (t,
J¼7.6 Hz, 1H), 7.04 (t, J¼10.2 Hz, 1H), 6.97 (t, J¼10.4 Hz, 1H), 4.33 (q,
J¼7.2 Hz, 2H), 4.31 (q, J¼7.2 Hz, 2H), 1.29(8) (t, J¼7.2 Hz, 3H), 1.29(7)
(t, J¼7.2 Hz, 3H); 1H NMR (CDCl3, 400 MHz)
9.04 (t, J¼8.0 Hz, 1H),
d
8.64 (t, J¼7.8 Hz, 1H), 7.11 (t, J¼9.8 Hz, 1H), 7.04 (t, J¼10.2 Hz, 1H),
4.44 (q, J¼7.2 Hz, 2H), 4.42 (q, J¼7.2 Hz, 2H), 1.42 (t, J¼7.2 Hz, 3H),
1.41 (t, J¼7.2 Hz, 3H); 19F NMR (CDCl3, 376 MHz)
d
ꢁ35.5, ꢁ37.7,
ꢃ
ꢁ41.1, ꢁ44.6; MS (EIþ) m/z 414 (Mþ , 100%), 394 (85), 369 (63), 213
(37), 199 (88), 157 (79), 140 (46), 115 (43), 101 (37); MS (ESI) m/z 415
ꢃ
([MþH]þ, 100%), 395 (4); HRMS (EIþ) found: Mþ , 414.0828.
ꢃ
C18H14O5N2F4 requires Mþ , 414.0839.
isomer. 1H NMR (CDCl3, 400 MHz)
d
8.41 (t, J¼8.2 Hz, 2H, E-isomer),
4.8. Compound 22
7.67 (t, J¼7.8 Hz, 2H, Z-isomer), 7.11 (t, J¼10.2 Hz, 2H, E-isomer), 6.81
(t, J¼9.6 Hz, 2H, Z-isomer), 4.43 (q, J¼7.2 Hz, 4H, E-isomer), 4.37 (q,
J¼7.2 Hz, 4H, Z-isomer), 1.42 (t, J¼7.2 Hz, 6H, E-isomer), 1.37 (t,
1H NMR (CF3CD2OD, 400 MHz)
d
6.88 (d, J¼3.2 Hz, 1H), 5.96 (d,
J¼13.6 Hz, 1H), 4.20 (q, J¼7.2 Hz, 2H), 1.19 (t, J¼7.2 Hz, 3H); 13C NMR
J¼7.2 Hz, 6H, Z-isomer); 1H NMR (CF3CD2OD, 400 MHz)
d
8.32
d
164.3 (d, JC–F¼2 Hz), 139.3 (d, JC–F¼20 Hz), 119.9 (d, JC–F¼4 Hz),
(t, J¼8.0 Hz, 2H, E-isomer), 7.55 (t, J¼7.6 Hz, 2H, Z-isomer), 7.02
(t, J¼10.4 Hz, 4H, E-isomer), 6.79 (t, J¼10.0 Hz, 2H, Z-isomer), 4.31
(q, J¼7.2 Hz, 4H, E-isomer), 4.23 (q, J¼7.2 Hz, 4H, Z-isomer), 1.29
(t, J¼7.2 Hz, 6H, E-isomer), 1.23 (t, J¼7.2 Hz, 6H, Z-isomer); 13C NMR
104.2 (dd, JC–F¼33 and 79 Hz), 65.5, 14.1, three signals were over-
lapping or obscured; MS (ESI): m/z 200 ((MþH)þ, 100%), 173 (8), 171
(42), 170 (34).
(CDCl3, 101 MHz)
d
164.1 (dd, JC–F¼12 and 270 Hz, E-isomer), 162.7
4.9. Compound 25
(dd, JC–F¼12 and 269 Hz, E-isomer), 163.0 (dd, JC–F¼4 Hz, E-isomer),
162.3 (dd, JC–F¼5 Hz, E-isomer), 125.9 (Z-isomer), 122.3 (E-isomer),
106.7 (dd, JC–F¼24 and 27 Hz, E-isomer), 61.8(9) (Z-isomer), 61.8(6)
MS (ESI): m/z 273 ((MþH)þ, 100%), 247 (10), 200 (5), 86 (90),
74 (25).